Your search history is turned on.
Date: April 26, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Microsoft Word - MCR- Private Placement (April 2024)v.2.docx FORM 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company Avicanna Inc. (the "Company") 480 University Avenue, Suite 1502 Toronto, Ontario M5G 1V2 Item 2. Date of Material Change April 18, 2024 Item 3. News Release News release in respect to the material change referre...
Microsoft Word - MCR- Private Placement (April 2024).docx FORM 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company Avicanna Inc. (the "Company") 480 University Avenue, Suite 1502 Toronto, Ontario M5G 1V2 Item 2. Date of Material Change April 18, 2024 Item 3. News Release News release in respect to the material change referred t...
Date: April 26, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Create report of exempt distribution (Form 45-106F1) Form 45-106F1 Report of Exempt Distribution ITEM 1 - REPORT TYPE New report Amended report If amended, provide filing date of report that is being amended. (YYYY-MM-DD) ITEM 2 - PARTY CERTIFYING THE REPORT Indicate the party certifying the report (select only one). For guidance regarding whether an ...
Date: April 18, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Avicanna Announces Closing of Non-brokered Private Placement TORONTO, April 18, 2024 -- Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid- based products is pleased to announce that it has closed a non-brokered private placement offering of 5,313,959 units...
Date: April 10, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study The study results revealed improvements in symptoms and quality of life in patients with musculoskeletal pain and inflammation TORONTO, April 10, 2024 -- Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commer...
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Avicanna Reports Full Year 2023 Audited Financial Results $16.8M in Revenue, representing an increase of 314% from 2022 $6.7M Consolidated gross Profit, representing an increase of 500% from 2022 TORONTO, April 02, 2024 -- Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of pla...
Date: April 1, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
1 Form 52-109F1 Certification of Annual Filings Full Certificate I, Phillip Cardella, Chief Financial Officer of Avicanna Inc., certify the following: 1. Review: I have reviewed the Annual Information Form (AIF), if any, annual financial statements and annual Management Discussion and Analysis (MD&A), including, for greater certainty, all docu...
1 Form 52-109F1 Certification of Annual Filings Full Certificate I, Aras Azadian, Chief Executive Officer of Avicanna Inc., certify the following: 1. Review: I have reviewed the Annual Information Form (AIF), if any, annual financial statements and annual Management Discussion and Analysis (MD&A), including, for greater certainty, all document...
ANNUAL INFORMATION FORM FOR THE PERIOD ENDED DECEMBER 31, 2023 Dated: April 1, 2024 2 TABLE OF CONTENTS GLOSSARY OF CERTAIN TERMS ........................................................................................... 3 FORWARD-LOOKING INFORMATION .......................
Page | 2 Special Note Regarding Forward-Looking Statements This managements discussion and analysis ("MD&A") of Avicanna Inc. ("Avicanna" or the "Company") contains "forward-looking information" within the meaning of Canadian securities legislation ("forward-looking statements"). These forward-looking statements are mad...